Rupa Narayan

1.3k total citations
34 papers, 350 citations indexed

About

Rupa Narayan is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Rupa Narayan has authored 34 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Rupa Narayan's work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Rupa Narayan is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Rupa Narayan collaborates with scholars based in United States, United Kingdom and Spain. Rupa Narayan's co-authors include Rajni Rani, Noah Craft, Kevin W. Bruhn, Andrew M. Brunner, Debra K. Czerwinski, Valentina Nardi, Bruno C. Medeiros, Liora M. Schultz, Joshua E. Elias and Michael S. Khodadoust and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rupa Narayan

30 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupa Narayan United States 11 134 126 119 107 51 34 350
Donata Urbaniak‐Kujda Poland 12 98 0.7× 88 0.7× 130 1.1× 91 0.9× 46 0.9× 37 416
Colton Smith United States 9 143 1.1× 152 1.2× 130 1.1× 123 1.1× 144 2.8× 19 516
Katarzyna Kapelko‐Słowik Poland 11 94 0.7× 85 0.7× 78 0.7× 84 0.8× 33 0.6× 25 336
Eleonora Malerba Italy 8 124 0.9× 98 0.8× 89 0.7× 62 0.6× 10 0.2× 12 354
Toshiki Terao Japan 11 135 1.0× 72 0.6× 115 1.0× 157 1.5× 20 0.4× 60 377
Tomoko Yokosuka Japan 10 51 0.4× 83 0.7× 66 0.6× 57 0.5× 46 0.9× 28 271
Takahide Ara Japan 9 69 0.5× 107 0.8× 93 0.8× 159 1.5× 62 1.2× 54 324
Tainá Gomes Brazil 9 227 1.7× 276 2.2× 71 0.6× 45 0.4× 16 0.3× 13 493
Noriharu Sato Japan 12 155 1.2× 117 0.9× 134 1.1× 65 0.6× 19 0.4× 20 448
T Shibuya Japan 8 171 1.3× 168 1.3× 79 0.7× 218 2.0× 32 0.6× 13 465

Countries citing papers authored by Rupa Narayan

Since Specialization
Citations

This map shows the geographic impact of Rupa Narayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupa Narayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupa Narayan more than expected).

Fields of papers citing papers by Rupa Narayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupa Narayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupa Narayan. The network helps show where Rupa Narayan may publish in the future.

Co-authorship network of co-authors of Rupa Narayan

This figure shows the co-authorship network connecting the top 25 collaborators of Rupa Narayan. A scholar is included among the top collaborators of Rupa Narayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupa Narayan. Rupa Narayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amrein, Philip C., Amir Fathi, Gabriela Hobbs, et al.. (2025). Real-world outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia treated with IDH1 and IDH2 inhibitors in the frontline setting. Blood. 146(Supplement 1). 8171–8171.
2.
Brunner, Andrew M., Yiwen Liu, Rupa Narayan, et al.. (2024). Safety and Activity of the TIM3 Inhibitor Sabatolimab in Patients with Lower-Risk Myelodysplastic Syndromes. Blood. 144(Supplement 1). 6726–6726. 1 indexed citations
3.
Narayan, Rupa, Ana Alfonso Piérola, William B. Donnellan, et al.. (2024). First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and Translational Science. 17(3). e13742–e13742. 14 indexed citations
4.
Amrein, Philip C., Andrew M. Brunner, Amir T. Fathi, et al.. (2024). Retrospective Single-Institution Review of Bosutinib Dose Optimization for Efficacy and Safety with Dose Ramp-up and Titration. Blood. 144(Supplement 1). 6591–6591.
5.
Brunner, Andrew M., Yiwen Liu, Jacqueline S. Garcia, et al.. (2024). Clinical Activity and Safety of the Oral ATR Inhibitor Ceralasertib (AZD6738) in Patients with MDS or CMML after Prior HMA Therapy. Blood. 144(Supplement 1). 1833–1833. 1 indexed citations
6.
Lee, Michelle, Harrison Tsai, Daniel J. DeAngelo, et al.. (2024). Tyrosine Kinase Inhibitor (TKI) Response in Patients with Chronic Myelogenous Leukemia (CML) and BCR-ABL 35 Base Pair Intron 8 Insertion (35INS). Blood. 144(Supplement 1). 6598–6598.
7.
Fathi, Amir T., Geoffrey Fell, Areej El‐Jawahri, et al.. (2022). A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Conventional Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia. Blood. 140(Supplement 1). 3284–3286. 2 indexed citations
8.
Lo, Ying‐Chun, Rupa Narayan, Valentina Nardi, & Jochen K. Lennerz. (2021). Two In Cis Variants—Two Worlds Apart. The Oncologist. 26(12). 997–999. 1 indexed citations
9.
Narayan, Rupa, Ann Lazar, R. Fong, et al.. (2020). Modified Hyper-CVAD With Proteasome Inhibition for Multiple Myeloma: A Single-Center Retrospective Analysis. Clinical Lymphoma Myeloma & Leukemia. 20(12). e961–e985. 6 indexed citations
10.
Nardi, Valentina, Nora Ku, Matthew J. Frigault, et al.. (2020). Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement. Blood Advances. 4(1). 106–111. 22 indexed citations
11.
Kasbekar, Monica, Valentina Nardi, Paola Dal Cin, et al.. (2020). Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia. Blood Advances. 4(13). 3136–3140. 28 indexed citations
12.
Narayan, Rupa, Jonathan Benjamin, Omid Shah, et al.. (2019). Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms. Biology of Blood and Marrow Transplantation. 25(7). 1293–1303. 17 indexed citations
13.
Millar, David G., Chuan Yan, Songfa Zhang, et al.. (2019). Redirecting T-Cells Against AML in a Multidimensional Targeting Space Using T-Cell Engaging Antibody Circuits (TEAC). Blood. 134(Supplement_1). 2653–2653. 6 indexed citations
14.
Narayan, Rupa, Niclas Olsson, Lisa E. Wagar, et al.. (2019). Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin. PLoS ONE. 14(7). e0219547–e0219547. 34 indexed citations
15.
Tan, Marisela, Evan Kalin-Hajdu, Rupa Narayan, Sandy W. Wong, & Thomas Martin. (2018). Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. Journal of Oncology Pharmacy Practice. 25(5). 1253–1257. 4 indexed citations
16.
Shah, Nina, Jeffrey L. Wolf, Sandy W. Wong, et al.. (2017). A single-center retrospective cohort analysis of venetoclax in post-transplant, relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. 35(15_suppl). e19514–e19514. 1 indexed citations
17.
Arora, Shagun, et al.. (2015). Sex Determination by Applying Discriminant Functional Analysis on Patellar Morphometry. International Journal of Science and Research (IJSR). 4(11). 1511–1515. 9 indexed citations
18.
Bruhn, Kevin W., Ron Birnbaum, Rupa Narayan, et al.. (2012). Killed but Metabolically Active Leishmania infantum as a Novel Whole-Cell Vaccine for Visceral Leishmaniasis. Clinical and Vaccine Immunology. 19(4). 490–498. 25 indexed citations
19.
Narayan, Rupa, Shanli Tsui, Tamiko Konishi, et al.. (2011). Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma. Journal of Investigative Dermatology. 132(1). 163–169. 44 indexed citations
20.
Rani, Rajni, et al.. (1998). Role of HLA‐B and C alleles in development of psoriasis in patients from North India. Tissue Antigens. 51(6). 618–622. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donata Urbaniak‐Kujda Breakdown of academic impact, for papers by Colton Smith Breakdown of academic impact, for papers by Katarzyna Kapelko‐Słowik Breakdown of academic impact, for papers by Eleonora Malerba Breakdown of academic impact, for papers by Toshiki Terao Breakdown of academic impact, for papers by Tomoko Yokosuka Breakdown of academic impact, for papers by Takahide Ara Breakdown of academic impact, for papers by Tainá Gomes Breakdown of academic impact, for papers by Noriharu Sato Breakdown of academic impact, for papers by T Shibuya
Rankless by CCL
2026